Showing results (101-110 of 399) with videos related to

Sort By:
Pageof 40
Oncotarget|March 10, 2016
Insulin receptor substrate 1 is a substrate of the Pim protein kinasesJin H Song, Sathish K R Padi, Libia A Luevano, et al.
Cells|November 26, 2022
Distinct Dynamics of Migratory Response to PD-1 and CTLA-4 Blockade Reveals New Mechanistic Insights for Potential T-Cell Reinvigoration following Immune Checkpoint BlockadeFateme Safaeifard, Bahram Goliaei, Amir R Aref, et al.
Blood Reviews|March 16, 2024
Targeting hematologic malignancies by inhibiting E-selectin: A sweet spot for AML therapy?Geoffrey L Uy, Daniel J DeAngelo, Jay N Lozier, et al.
Leukemia|March 28, 2024
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patientsShai Shimony, Jacqueline S Garcia, Julia Keating, et al.
Blood|April 21, 2009
Identification of AML1-ETO modulators by chemical genomicsSteven M Corsello, Giovanni Roti, Kenneth N Ross, et al.
Small Methods|April 4, 2022
A Robust Method for Perfusable Microvascular Network Formation In VitroZhengpeng Wan, Amy X Zhong, Shun Zhang, et al.
The Journal of Clinical Investigation|September 7, 2016
Functionally identifiable apoptosis-insensitive subpopulations determine chemoresistance in acute myeloid leukemiaPatrick D Bhola, Brenton G Mar, R Coleman Lindsley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host diseaseDaniel J DeAngelo, Ephraim P Hochberg, Edwin P Alyea, et al.
Journal of Neuropathology and Experimental Neurology|July 31, 2018
Neuropathology of a Case With Fatal CAR T-Cell-Associated Cerebral EdemaMatthew Torre, Isaac H Solomon, Claire L Sutherland, et al.
Blood Advances|October 5, 2021
Orthopedic toxicities among adolescents and young adults treated in DFCI ALL Consortium TrialsYannis K Valtis, Kristen E Stevenson, Andrew E Place, et al.
Pageof 40